Current Drug Targets logo Bentham Science Publishers logo

Current Drug Targets aims to cover the latest and most outstanding developments on the medicinal chemistry and pharmacology of molecular drug targets e.g. disease specific proteins, receptors, enzymes, genes. Each issue of the journal will be devoted to a single timely topic, with series of in-depth reviews, written by leaders in the field, covering a range of current topics on drug targets. These issues will be organized and led by a guest editor who is a recognized expert in the overall topic. As the discovery, identification, characterisation and validation of novel human drug targets for drug discovery continues to grow; this journal will be essential reading for all pharmaceutical scientists involved in drug discovery and development.

Publisher: Bentham Science Publishers

Related content
Volume 6, Number 4, June 2005

< previous issue | all issues | next issue >

Review article

Oxidized Galectin-1 is an Essential Factor for Peripheral Nerve Regeneration
pp. 385-394(10)
Authors: Horie, Hidenori; Kadoya, Toshihiko; Sango, Kazunori; Hasegawa, Mitsuhiro

Galectin-1 as a Potential Therapeutic Agent for Amyotrophic Lateral Sclerosis
pp. 407-418(12)
Authors: Kato, T.; Ren, C.- H.; Wada, M.; Kawanami, T.

Expression and Functions of Galectin-1 in Sensory and Motoneurons
pp. 419-425(7)
Authors: Gaudet, A. D.; Steeves, J. D.; Tetzlaff, W.; Ramer, M. S.

Regulation of the Neuronal Fate by DgrFosB and its Downstream Target, Galectin-1
pp. 437-444(8)
Authors: Miura, Tomofumi; Ohnishi, Yoshinori; Kurushima, Hideaki; Horie, Hidenori; Kadoya, Toshihiko; Nakabeppu, Yusaku

Book review

Review article

Blockade of Diabetic Vascular Injury by Controlling of AGE-RAGE System
pp. 447-452(6)
Authors: Myint, Khin M.; Yamamoto, Yasuhiko; Sakurai, Shigeru; Harashima, Ai; Watanabe, Takuo; Li, Hui; Takeuchi, Akihiko; Yoshimura, Kazunobu; Yonekura, Hideto; Yamamoto, Hiroshi

The Role of AGEs and AGE Inhibitors in Diabetic Cardiovascular Disease
pp. 453-474(22)
Authors: Thomas, M. C.; Baynes, J. W.; Thorpe, S. R.; Cooper, M. E.

Aldose Reductase in Diabetic Microvascular Complications
pp. 475-486(12)
Authors: Chung, S. S.M.; Chung, S. K.

Molecular Targets of Diabetic Cardiovascular Complications
pp. 487-494(8)
Authors: Ahmad, Fatima K.; He, Zhiheng; King, George L.

Molecular Targets of Diabetic Vascular Complications and Potential New Drugs
pp. 503-509(7)
Authors: Ros, Roberto D.; Assaloni, Roberta; Ceriello, Antonio

Vascular Endothelial Growth Factor and Diabetic Retinopathy: Role of Oxidative Stress
pp. 511-524(14)
Authors: Caldwell, Ruth B.; Bartoli, Manuela; Behzadian, M. A.; El-Remessy, Azza E.B.; Al-Shabrawey, Mohamed; Platt, Daniel H.; Liou, Gregory I.; Caldwell, R. W.i.l.l.i.a.m.

Adipokines: Therapeutic Targets for Metabolic Syndrome
pp. 525-529(5)
Authors: Kobayashi, Kunihisa; Inoguchi, Toyoshi

< previous issue | all issues | next issue >

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page